Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 33,2024 No.6 Detail

Application progress of esketamine in gynecology and obstetrics during perioperative period

Published on Jul. 02, 2024Total Views: 63 times Total Downloads: 29 times Download Mobile

Author: CONG Xiaojing 1 GUAN Yingchao 2 YU Songyang 1, 2

Affiliation: 1. The Second School of Clinical Medicine of Binzhou Medical University, Yantai 264000, Shandong Province, China 2. Department of Anesthesiology, Weihai Municipal Hospital Affiliated to Shandong University, Weihai 264200, Shandong Province, China

Keywords: Esketamine Anesthesia Obstetrics and gynecology Postnatal depression

DOI: 10.12173/j.issn.1005-0698.202404019

Reference: CONG Xiaojing, GUAN Yingchao, YU Songyang.Application progress of esketamine in gynecology and obstetrics during perioperative period[J].Yaowu Liuxingbingxue Zazhi,2024, 33(6):697-706.DOI: 10.12173/j.issn.1005-0698.202404019.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

The volume of gynecological and obstetric surgeries is large, and the high rates of adverse events incidence such as perioperative cycle fluctuations, postoperative nausea and vomiting and adverse emotional experiences, which is a concern for clinicians. Esketamine is a right-handed isomer of ketamine with a strong affinity for the N-methyl-D-aspartate receptor (NMDAR), which has a rapid anesthetic, analgesic and antidepressant effect. It can be administered through multiple routes and has been widely used in clinical anesthesia, postoperative analgesia and depression treatment. The application of esketamine injection in clinical practice is still relatively short, and the benefits and mechanisms during perioperative application have not been fully elucidated, making it a research hotspot in recent years. Many studies have reported that the application of esketamine injection in obstetrics and gynecology surgery can stabilize circulation, and reduce respiratory depression, nausea and vomiting and other adverse reactions. It is also beneficial for the prevention and treatment of postpartum depression under certain conditions, but sometimes there are also temporary pseudo-psychiatric symptoms and other adverse reactions. In this article, we review the pharmacological effects, perioperative application and impact on postoperative recovery of esketamine based on the specialty characteristics of obstetrics and gynecology surgery, and clarify its current application status, as well as possible clinical applications and research directions in the future, to provide reference for the clinicians.

Full-text
Please download the PDF version to read the full text: download
References

1.Athnaiel O, Cantillo S, Paredes S, et al. The role of sex hormones in pain-related conditions[J]. Int J Mol Sci, 2023, 24(3): 1866. DOI: 10.3390/ijms24031866.

2.Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting[J]. Anesth Analg, 2020, 131(2): 411-448. DOI: 10.1213/ane.0000000000004833.

3.艾司氯胺酮临床应用专家指导意见专家组. 艾司氯胺酮临床应用专家指导意见[J]. 国际麻醉学与复苏杂志, 2023, 44(8): 785-793. DOI: 10.3760/cma.j.cn321761-20230603-00852.

4.Jelen LA, Young AH, Stone JM. Ketamine: a tale of two enantiomers[J]. J Psychopharmacol, 2021, 35(2): 109-123. DOI: 10.1177/0269881120959644.

5.Kohtala S. Ketamine-50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms[J]. Pharmacol Rep, 2021, 73(2): 323-345. DOI: 10.1007/s43440-021-00232-4.

6.Zhang Y, Ye F, Zhang T, et al. Structural basis of ketamine action on human NMDA receptors[J]. Nature, 2021, 596(7871): 301-305. DOI: 10.1038/s41586-021-03769-9.

7.Pacheco Dda F, Romero TR, Duarte ID. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors[J]. Brain Res, 2014, 1562: 69-75. DOI: 10.1016/j.brainres. 2014.03.026.

8.Subramanian S, Haroutounian S, Palanca BJA, et al. Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence[J]. J Neurol Sci, 2022, 434: 120152. DOI: 10.1016/j.jns.2022.120152.

9.Yang Y, Maher DP, Cohen SP. Emerging concepts on the use of ketamine for chronic pain[J]. Expert Rev Clin Pharmacol, 2020, 13(2): 135-146. DOI: 10.1080/ 17512433.2020.1717947.

10.Riva-Posse P, Reiff CM, Edwards JA, et al. Blood pressure safety of subanesthetic ketamine for depression: a report on 684 infusions[J]. J Affect Disord, 2018, 236: 291-297. DOI: 10.1016/j.jad.2018.02.025.

11.Gateau O, Bourgain JL, Gaudy JH, et al. Effects of ketamine on isolated human bronchial preparations[J]. Br J Anaesth, 1989, 63(6): 692-695. DOI: 10.1093/bja/63.6.692.

12.郑世红, 王建松, 王海霞, 等. 氯胺酮复合麻醉方案在肥胖患者无痛胃镜检查中的应用[J]. 药物流行病学杂志, 2022, 31(9): 586-590. [Zheng SH, Wang JS, Wang HX, et al. Effect and safety of ketamine combined anesthesia regimen in painless gastroscopy for patients with obesity[J]. Chinese Journal of Pharmacoepidemiology, 2022, 31(9): 586-590.] DOI: 10.19960/j.cnki.issn1005-0698.2022.09.002.

13.Zheng L, Wang Y, Ma Q, et al. Efficacy and safety of a subanesthetic dose of esketamine combined with propofol in patients with obesity undergoing painless gastroscopy: a prospective, double-blind, randomized controlled trial[J]. Drug Des Devel Ther, 2023, 17: 1347-1356. DOI: 10.2147/dddt.S408076.

14.庄心良, 曾因明, 陈伯銮, 主编. 现代麻醉学, 第5版 [M]. 北京: 人民卫生出版社, 2020: 624-629.

15.Zanos P, Moaddel R, Morris PJ, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms[J]. Pharmacol Rev, 2018, 70(3): 621-660. DOI: 10.1124/pr.117.015198.

16.White PF, Schüttler J, Shafer A, et al. Comparative pharmacology of the ketamine isomers. studies in volunteers[J]. Br J Anaesth, 1985, 57(2): 197-203. DOI: 10.1093/bja/57.2.197.

17.中华医学会妇产科学分会加速康复外科协作组. 妇科手术加速康复的中国专家共识[J]. 中华妇产科杂志, 2019, 54(2): 73-79. DOI: 10.3760/cma.j.issn.0529-567x.2019.02.001.

18.Feenstra ML, Jansen S, Eshuis WJ, et al. Opioid-free anesthesia: a systematic review and Meta-analysis[J]. J Clin Anesth, 2023, 90: 111215. DOI: 10.1016/j.jclinane. 2023.111215.

19.吴靦, 代文化, 曾伟, 等. 基于加速康复外科理念的去阿片化麻醉镇痛在急诊剖宫产围手术期运用观察 [J]. 药物流行病学杂志, 2023, 32(2): 166-172. [Wu M, Dai  WH, Zeng W, et al. Application of deopioid anesthesia and analgesia based on enhanced recovery after surgery in the perioperative period of emergency cesarean section[J]. Chinese Journal of Pharmacoepidemiology, 2023, 32(2): 166-172.] DOI: 10.19960/j.issn.1005-0698.202302006.

20.Chen L, He W, Liu X, et al. Application of opioid-free general anesthesia for gynecological laparoscopic surgery under ERAS protocol: a non-inferiority randomized controlled trial[J]. BMC Anesthesiol, 2023, 23(1): 34. DOI: 10.1186/s12871-023-01994-5.

21.Massoth C, Schwellenbach J, Saadat-Gilani K, et al. Impact of opioid-free anaesthesia on postoperative nausea, vomiting and pain after gynaecological laparoscopy - a randomised controlled trial[J]. J Clin Anesth, 2021, 75: 110437. DOI: 10.1016/j.jclinane.2021.110437.

22.张勋玉, 陈受琳. 艾司氯胺酮联合罗哌卡因超声引导下腹横肌平面阻滞在全子宫切除术中的应用[J]. 吉林医学, 2023, 44(8): 2222-2225. [Zhang XY, Chen SL. The use of esketamine combined with ropivacaine ultrasound-guided transverse abdominis plane block in total hysterectomy[J]. Jilin Medical Journal, 2023, 44(8): 2222-2225.] DOI: 10.3969/j.issn.1004-0412.2023.08.053.

23.张发龙, 朱宏, 李涛. 艾司氯胺酮用于腹腔镜全子宫切除术患者的效果观察[J]. 医学理论与实践, 2023, 36(21): 3685-3688. [Zhang FL, Zhu H, Li T. Observation of the effect of esketamine in patients undergoing laparoscopic total hysterectomy[J]. The Journal of Medical Theory and Practice 2023, 36(21): 3685-3688.] DOI: 10.19381/j.issn.1001-7585.2023.21.032.

24.刘俊鹭, 张晓东, 邹彬, 等. 艾司氯胺酮超前镇痛在腹腔镜下全子宫切除术中的应用效果分析[J]. 实用药物与临床, 2023, 26(4): 335-339. [Liu JL, Zhang XD, Zou B, et al. Effect of esketamine preemptive analgesia in laparoscopic total hysterectomy[J]. Practical Pharmacy and Clinical Remedies, 2023, 26(4): 335-339.] DOI: 10.14053/j.cnki.ppcr.202304010.

25.刘锴锐, 严北清, 刘春梅. 艾司氯胺酮注射液复合瑞芬太尼注射剂用于腹腔镜妇科手术患者的临床研究[J]. 中国临床药理学杂志, 2023, 39(11): 1547-1551. [Liu  KR, Yan BQ, Liu CM. Clinical trial of esketamine injection combined with remifentanil injection in the treatment of patients undergoing laparoscopic gynecologic surgery[J]. The Chinese Journal of Clinical Pharmacology, 2023, 39(11): 1547-1551.] DOI: 10.13699/j.cnki.1001-6821. 2023.11.006.

26.潘宗怀, 张学湖. 小剂量艾司氯胺酮复合瑞芬太尼用于腹腔镜子宫肌瘤剔除术效果观察[J]. 浙江医学, 2023, 45(2): 159-162, 167. [Pan ZH, Zhang XH. Efficacy and safety of esketamine combined with remifentanil in patients undergoing laparoscopic uterine myomectomy[J]. Zhejiang Medical Journal, 2023, 45(2): 159-162, 167.] DOI: 10.12056/j.issn.1006-2785.2023.45.2.2022-1457.

27.赵嫣红, 蒋海卿, 许媛媛, 等. 艾司氯胺酮联合丙泊酚对腹腔镜全子宫切除术患者血清炎症因子和应激反应的影响[J]. 现代生物医学进展, 2023, 23(20): 3836-3840, 3864. [Zhao YH, Jiang HQ, Xu YY, et al. Effect of esketamine combined with propofol on serum inflammatory factors and stress response in patients undergoing laparoscopic total hysterectomy[J]. Progress in Modern Biomedicine, 2023, 23(20): 3836-3840, 3864.] DOI: 10.13241/j.cnki.pmb.2023.20.007.

28.Zhou N, Liang X, Gong J, et al. S-ketamine used during anesthesia induction increases the perfusion index and mean arterial pressure after induction: a randomized, double-blind, placebo-controlled trial[J]. Eur J Pharm Sci, 2022, 179: 106312. DOI: 10.1016/j.ejps.2022.106312.

29.Wang J, Liu Y, Xu Q. Effects of esketamine combined with propofol for hysteroscopy anesthesia on patient hemodynamics and adverse reactions[J]. Altern Ther Health Med, 2024, 30(1): 18-23. https://pubmed.ncbi.nlm.nih.gov/37773657/.

30.钱夏丽, 夏凡, 沈晓凤, 等. 艾司氯胺酮复合丙泊酚在宫腔镜检查术中的应用[J]. 临床麻醉学杂志, 2021, 37(7): 706-708. [Qian XL, Xia F, Shen XF, et al. Application of esketamine combined with propofol in hysteroscopy[J]. Journal of Clinical Anesthesiology, 2021, 37(7): 706-708.] DOI: 10.12089/jca.2021.07.007.

31.王哲, 王海燕, 吕志敢, 等. 艾司氯胺酮与舒芬太尼联合丙泊酚用于宫腔镜手术麻醉效果比较[J]. 中国药业, 2023, 32(1): 91-93. [Wang Z, Wang HY, Lyu ZG, et al. Comparison of anesthetic effects of ssketamine combined with propofol and sufentanil combined with propofol in hysteroscopy[J]. China Pharmaceuticals, 2023, 32(1): 91-93.] DOI: 10.3969/j.issn.1006-4931.2023.01.022.

32.周丁香. 艾司氯胺酮联合丙泊酚应用于宫腔镜下子宫内膜息肉电切的安全性及有效性[J]. 吉林医学, 2023, 44(10): 2851-2854. [Zhou DX. Safety and efficacy of esketamine combined with propofol in hysteroscopic electroresection of endometrial polyps[J]. Jilin Medical Journal, 2023, 44(10): 2851-2854.] DOI: 10.3969/j.issn.1004-0412.2023.10.051.

33.沈燕平, 殷利军, 庄文明. 小剂量艾司氯胺酮预防无痛人工流产患者丙泊酚注射痛的效果[J]. 临床麻醉学杂志, 2022, 38(12): 1269-1273. [Shen YP, Yin LJ, Zhuang WM. Effect of low-does of esketamine on propofol injection pain in patients undergoing painless abortion[J]. Journal of Clinical Anesthesiology, 2022, 38(12): 1269-1273.] DOI: 10.12089/jca.2022.12.007.

34.张宁丽, 周臣, 思永玉, 等. 艾司氯胺酮复合丙泊酚在无痛人流术中的应用[J]. 昆明医科大学学报, 2023, 44(5): 102-106. [Zhang NL, Zhou C, Si YY, et al. Clinical application of esketamine combined with propofol in painless abortion[J]. Journal of Kunming Medical University, 2023, 44(5): 102-106.] DOI: 10.12259/j.issn.2095-610X.S20230514.

35.薛孟, 任应斌, 田瑞丽. 基于Cite Space文献分析并观察不同剂量艾司氯胺酮在无痛人工流产术应用效果[J]. 中国计划生育学杂志, 2024, 32(3): 527-532. [Xue M, Ying YB, Tian RL. Application effect of the different dosages of esketamine used in painless induced abortion based on Cite Space literature analysis[J]. Chinese Journal of Family Planning, 2024, 32(3): 527-532.] DOI: 10.3969/j.issn.1004-8189.2024.03.009.

36.张亚男, 刘禹含, 马晓婧. 艾司氯胺酮对无痛人工流产术女性生命体征与舒适度的改善作用[J]. 中国计划生育学杂志, 2023, 31(8): 1802-1806. [Zhang YN, Liu YH, Ma  XJ. Effect of esketamine for improvement of vital signs and comfort of women in painless sugical abortion[J]. Chinese Journal of Family Planning, 2023, 31(8): 1802-1806.] DOI: 10.3969/j.issn.1004-8189.2023.08.007.

37.Chen J, Zou X, Hu B, et al. Effect of different doses of esketamine compared with fentanyl combined with propofol on hypotension in patients undergoing painless abortion surgery: a prospective, randomized, double-blind controlled clinical trial[J]. BMC Anesthesiol, 2022, 22(1): 305. DOI: 10.1186/s12871-022-01848-6.

38.Jiang M, Li Q, Mao M, et al. Evaluation of clinical effects of esketamine on depression in patients with missed miscarriage: a randomized, controlled, double-blind trial[J]. J Affect Disord, 2023, 329: 525-530. DOI: 10.1016/j.jad.2023.02.127.

39.Xu LL, Wang C, Deng CM, et al. Efficacy and safety of esketamine for supplemental analgesia during elective cesarean delivery: a randomized clinical trial[J]. JAMA Netw Open, 2023, 6(4): e239321. DOI: 10.1001/jamanetworkopen.2023.9321.

40.杨铎, 张隆盛, 黄熙扬, 等. 小剂量艾司氯胺酮防治剖宫产术中寒战及牵拉反应的有效性与安全性分析[J]. 现代医院, 2023, 23(10): 1600-1604. [Yang D, Zhang LS, Huang XY, et al. Efficacy and safety analysis of low dose esketamine in the prevention and treatment of shivering and traction reaction during cesarean section[J]. Modern Hospital, 2023, 23(10): 1600-1604.] DOI: 10.3969/j.issn.1671-332X.2023.10.035.

41.Zhang X, Wang J, An XH, et al. Optimum dose of spinal ropivacaine with or without single intravenous bolus of S-ketamine during elective cesarean delivery: a randomized, double-blind, sequential dose-finding study[J]. BMC Pregnancy Childbirth, 2021, 21(1): 746. DOI: 10.1186/s12884-021-04229-y.

42.Liang Z, Zhou T, Wang M, et al. Neonatal outcomes when intravenous esketamine is added to the parturients transferred from labor analgesia to emergency cesarean section: a retrospective analysis report[J]. BMC Anesthesiol, 2023, 23(1): 168. DOI: 10.1186/s12871-023-02132-x.

43.黄子娟, 王志萍, 梁宵. 艾司氯胺酮联合盐酸罗哌卡因对分娩镇痛及产后抑郁的影响[J]. 中南医学科学杂志, 2021, 49(6): 655-658. [Huang ZJ, Wang ZP, Liang X. Effects of esketamine combined with ropivacaine on labor analgesia and postpartum depression[J]. Medical Science Journal of Central South China, 2021, 49(6): 655-658.] DOI: 10.15972/j.cnki.43-1509/r.2021.06.009.

44.郑薇, 曹明, 陈倩, 等. 联用艾司氯胺酮对分娩镇痛和产后抑郁的影响[J]. 国际麻醉学与复苏杂志, 2024, 45(3): 249-252. [Zheng W, Cao M, Chen Q, et al. Effect of combined use of esketamine on labor analgesia and postpartum depression[J]. International Journal of Anesthesiology and Resuscitation, 2024, 45(3): 249-252.] DOI: 10.3760/cma.j.cn321761-20230808-00989.

45.牛莉, 韩焕芝, 孙静静, 等. 无痛分娩中应用不同剂量艾司氯胺酮效果及对产后抑郁影响[J]. 临床军医杂志, 2023, 51(4): 424-426. [Niu L, Han HZ, Sun JJ, et al. Effect of different doses of esketamine in painless delivery and its effect on postpartum depression[J]. Clinical Journal of Medical Officers, 2023, 51(4): 424-426.] DOI: 10.16680/j.1671-3826.2023.04.25.

46.Ma Y, Zhang R, Cao X, et al. Effects of intraoperative esketamine addition on gastrointestinal function after benign gynaecological laparoscopic surgery: a double-blind, randomized controlled study[J]. BMC Anesthesiol, 2023, 23(1): 220. DOI: 10.1186/s12871-023-02184-z.

47.Zhang T, Yue Z, Yu L, et al. S-ketamine promotes postoperative recovery of gastrointestinal function and reduces postoperative pain in gynecological abdominal surgery patients: a randomized controlled trial[J]. BMC Surg, 2023, 23(1): 74. DOI: 10.1186/s12893-023-01973-0.

48.Han T, Chen Q, Huang J, et al. Low-dose esketamine with sufentanil for postcesarean analgesia in women with gestational diabetes mellitus: a prospective, randomized, double-blind study[J]. Front Endocrinol (Lausanne), 2023, 14: 1202734. DOI: 10.3389/fendo.2023.1202734.

49.Ardalan M, Elfving B, Rafati AH, et al. Rapid effects of S-ketamine on the morphology of hippocampal astrocytes and BDNF serum levels in a sex-dependent manner[J]. Eur Neuropsychopharmacol, 2020, 32: 94-103. DOI: 10.1016/j.euroneuro.2020.01.001.

50.Schmitt K, Holsboer-Trachsler E, Eckert A. BDNF in sleep, insomnia, and sleep deprivation[J]. Ann Med, 2016, 48(1-2): 42-51. DOI: 10.3109/07853890.2015.1131327.

51.梁士权, 王建刚, 田首元, 等. 亚麻醉剂量艾司氯胺酮对全子宫切除术患者术后睡眠质量的影响[J]. 实用药物与临床, 2023, 26(2): 122-126. [Liang SQ, Wang JG, Tian SY, et al. Effects of sub-anesthetic dose of esketamine on postoperative sleep quality of patients undergoing total hysterectomy[J]. Practical Pharmacy and Clinical Remedies, 2023, 26(2): 122-126.] DOI: 10.14053/j.cnki.ppcr.202302006.

52.Qiu D, Wang XM, Yang JJ, et al. Effect of intraoperative esketamine infusion on postoperative sleep disturbance after gynecological laparoscopy: a randomized clinical trial[J]. JAMA Netw Open, 2022, 5(12): e2244514. DOI: 10.1001/jamanetworkopen.2022.44514.

53.Wang W, Xu H, Ling B, et al. Effects of esketamine on analgesia and postpartum depression after cesarean section: a randomized, double-blinded controlled trial[J]. Medicine (Baltimore), 2022, 101(47): e32010. DOI: 10.1097/md.0000000000032010.

54.Guo Y, Ding X, Wang S, et al. Analgesic effect of esketamine combined with tramadol for patient-controlled intravenous analgesia after cesarean section: a randomized controlled trial[J]. J Pain Res, 2023, 16: 3519-3528. DOI: 10.2147/jpr.S427702.

55.Lou F, Wang C, Dong X, et al. Analysis of the analgesic effect, emotion, and safety of esketamine in cesarean section analgesia for puerperae[J]. Altern Ther Health Med, 2023, 29(7): 424-428. https://pubmed.ncbi.nlm.nih.gov/37573591/.

56.中华医学会妇产科学分会产科学组. 围产期抑郁症筛查与诊治专家共识[J]. 中华妇产科杂志, 2021, 56(8): 521-527. DOI: 10.3760/cma.j.cn112141-20210115-00022.

57.Singh B, Kung S, Pazdernik V, et al. Comparative effectiveness of intravenous ketamine and intranasal esketamine in clinical practice among patients with treatment-refractory depression: an observational study[J]. J Clin Psychiatry, 2023, 84(2): 22m14548. DOI: 10.4088/JCP.22m14548.

58.Wang S, Deng CM, Zeng Y, et al. Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial[J]. BMJ, 2024, 385: e078218. DOI: 10.1136/bmj-2023-078218.

59.Ling B, Zhu Y, Yan Z, et al. Effect of single intravenous injection of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial[J]. BMC Pharmacol Toxicol, 2023, 24(1): 66. DOI: 10.1186/s40360-023-00705-7.

60.Wang W, Ling B, Chen Q, et al. Effect of pre-administration of esketamine intraoperatively on postpartum depression after cesarean section: a randomized, double-blinded controlled trial[J]. Medicine (Baltimore), 2023, 102(9): e33086. DOI: 10.1097/md.0000000000033086.

61.Li S, Zhou W, Li P, et al. Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: a meta-analysis[J]. J Affect Disord, 2024, 351: 720-728. DOI: 10.1016/j.jad.2024.01.202.

62.段柏情, 周秦, 李利平, 等. 艾司氯胺酮对剖宫产术后镇痛效果及产后抑郁的影响[J]. 中国医师杂志, 2023, 25(11): 1615-1618. [Duan BQ, Zhou Q, Li LP, et al. The effect of esketamine on postoperative analgesia and postpartum depression after cesarean section[J]. Journal of Chinese Physician, 2023, 25(11): 1615-1618.] DOI: 10.3760/cma.j.cn431274-20231016-00389.

63.邵晓宇, 梅欢, 杨进国. 艾司氯胺酮对剖宫产产妇术后镇痛及产后抑郁的影响[J]. 国际麻醉学与复苏杂志, 2023, 44(2): 160-164. [Shao XY, Mei H, Yang JG. Effect of esketamine on postoperative analgesia and postpartum depression in women undergoing caesarean section[J]. International Journal of Anesthesiology and Resuscitation, 2023, 44(2): 160-164.] DOI: 10.3760/cma.j.cn321761-20220119-00733.

64.Shen J, Song C, Lu X, et al. The effect of low-dose esketamine on pain and post-partum depression after cesarean section: a prospective, randomized, double-blind clinical trial[J]. Front Psychiatry, 2022, 13: 1038379. DOI: 10.3389/fpsyt.2022.1038379.

Popular papers
Last 6 months